Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Total 13F shares
-
123,010,848
-
Share change
-
-152,639
-
Total reported value
-
$29,508,708,117
-
Put/Call ratio
-
158%
-
Price per share
-
$239.92
-
Number of holders
-
984
-
Value change
-
-$87,864,895
-
Number of buys
-
360
-
Number of sells
-
535
Institutional Holders of BIOGEN INC. - COM (BIIB) as of Q4 2021
As of 31 Dec 2021 BIOGEN INC. - COM (BIIB) had 984 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 123,010,848 shares of stock of the company.
Largest 10 holders included PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, Clearbridge Investments, LLC, NORTHERN TRUST CORP, and DEUTSCHE BANK AG\.
This table shows 994 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.